Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16487290 | 0.91 | ALDH1A1 (0.48) | ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2 | |
| SCHEMBL30083985 | 0.91 | ALDH1A1 (0.48) | ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2 | |
| SCHEMBL3816833 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2 | |
| SCHEMBL621971 | 0.82 | CYP1A2 (0.54) | ALDH1A1CYP1A2TSHRCYP2A6XDH | |
| SCHEMBL31195248 | 0.82 | CYP1A2 (0.54) | ALDH1A1CYP1A2TSHRCYP2A6XDH | |
| SCHEMBL11709613 | 0.81 | AKR1B1 (0.59) | ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2 | |
| SCHEMBL1116335 | 0.80 | XDH (0.48) | ALDH1A1HSD17B10HIF1ACYP1A2TSHR | |
| Bromide SCHEMBL28224561 | 0.80 | CYP1A2 (0.52) | ALDH1A1CYP1A2TSHRCYP2A6XDH | |
| SCHEMBL4563164 | 0.80 | XDH (0.48) | ALDH1A1HSD17B10HIF1ACYP1A2TSHR | |
| SCHEMBL20873038 | 0.79 | XDH (0.38) | ALDH1A1CYP1A2CYP2D6CYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260003210-A1 | DIFFRACTIVE CONTACT LENSES | ALCON INC (CH) | 2026-01-01 | — | — | US | claimed |
| US-12379611-B2 | Diffractive contact lenses | ALCON INC. (CH) | 2025-08-05 | — | — | US | claimed |
| EP-4356169-A1 | MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2024-04-24 | — | — | EP | claimed |
| CN-117280252-A | Multifocal diffractive silicone hydrogel contact lenses | 爱尔康公司 | 2023-12-22 | — | — | CN | claimed |
| US-20230004023-A1 | DIFFRACTIVE CONTACT LENSES | ALCON INC. (CH) | 2023-01-05 | — | — | US | claimed |
| WO-2022263994-A1 | MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2022-12-22 | — | — | WO | claimed |
| WO-2026105013-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | ALCON INC. (CH) | 2026-05-21 | — | — | WO | disclosed |
| US-20260133439-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | ALCON INC. (CH) | 2026-05-14 | — | — | US | disclosed |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | ALCON INC (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20260104598-A1 | COMPOSITE CONTACT LENSES WITH ULTRATHIN OBJECTS | ALCON INC (CH) | 2026-04-16 | — | — | US | disclosed |
| EP-4719751-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719750-A1 | EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719753-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| CN-117280252-A | Multifocal diffractive silicone hydrogel contact lenses | 爱尔康公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-116888193-A | Polysiloxane vinyl cross-linking agent with high refractive index | 爱尔康公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230004023-A1 | DIFFRACTIVE CONTACT LENSES | ALCON INC. (CH) | 2023-01-05 | — | — | US | disclosed |
| WO-2022263994-A1 | MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022201013-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC. (CH) | 2022-09-29 | — | — | WO | disclosed |
| US-20220306810-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC. (CH) | 2022-09-29 | — | — | US | disclosed |
| WO-2015023001-A1 | NOVEL ORGANOPOLYSILOXANE, SURFACE TREATMENT AGENT COMPRISING THE SAME, RESIN COMPOSITION COMPRISING THE SAME, AND GELATINOUS PRODUCT OR CURED PRODUCT THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2015-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260133439-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | MYO1G, STRA6, GJA1 | ALDH1A1 2727/4885HSD17B10 2996/4885HIF1A 1174/4885 |
| US-20260003210-A1 | DIFFRACTIVE CONTACT LENSES | LBR, CRYZ, CRYAA | ALDH1A1 1323/4885HSD17B10 3823/4885HIF1A 92/4885 |
| US-20260104598-A1 | COMPOSITE CONTACT LENSES WITH ULTRATHIN OBJECTS | CRYZ, CRYAA, LIMA1 | ALDH1A1 1922/4885HSD17B10 3590/4885HIF1A 3407/4885 |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | DSG1, SDC1, DSP | ALDH1A1 3575/4885HSD17B10 3824/4885HIF1A 3076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.